HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
ID: 342929Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $750K

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/342929

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-054.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative aimed at translating research into practice to combat the overdose crisis in the United States. This grant (RFA-DA-23-054) encourages applications that focus on sustainable and scalable interventions to improve patient-centered care for substance use disorders, particularly addressing health disparities in underserved populations. The initiative emphasizes the importance of innovative solutions that engage community stakeholders and overcome systemic barriers to care. Eligible applicants include various institutions and organizations, with a total funding ceiling of $750,000 per award and a cumulative funding amount of up to $15 million for FY2023. Interested parties must submit their applications by March 20, 2025, and can find additional information at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    RFA-DA-23-054-Full-Announcement.html
    RFA-DA-23-054.html
    The HEAL Initiative, under the Department of Health and Human Services, aims to address the alarming overdose crisis in the U.S. by funding action-oriented research that translates findings into practice. Specifically, the funding opportunity (RFA-DA-23-054) encourages applications focusing on sustainable, scalable, and stigma-free interventions to enhance patient-centered substance use disorder care. The initiative seeks innovative solutions to systemic barriers, promoting the engagement of community stakeholders and addressing health disparities in underserved populations. Eligible applicants include higher education institutions, nonprofits, and government entities, with total funding of up to $15 million designated for FY2023. Applications must demonstrate preliminary data, stakeholder involvement, and robust strategies for implementation and scalability of proposed interventions. The document details crucial dates, application procedures, eligibility criteria, and review processes, emphasizing compliance and coordination among grantees. This initiative reflects a commitment to ending addiction-related struggles in the U.S. through evidence-based practices and collaborative research efforts.
    Similar Opportunities
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis" (RFA-DA-23-054), aimed at supporting innovative research that bridges the gap between research findings and practical applications to combat the opioid overdose crisis. This initiative emphasizes the need for stigma-free, patient-centered care systems and focuses on understudied areas related to overdose prevention, requiring applicants to present preliminary data for significant projects within a maximum project period of five years and a budget of up to $750,000 in direct costs annually. The funding reflects a commitment to addressing health disparities and promoting effective addiction treatment and recovery solutions, with applications evaluated based on significance, innovation, feasibility, and stakeholder engagement. Interested applicants should note that the application deadline is March 20, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the HEAL Initiative funding opportunity titled "Translating Research to Practice to End the Overdose Crisis" (RFA-DA-23-053). This initiative aims to support research that translates findings into actionable practices to combat the ongoing overdose crisis in the U.S., with a focus on developing innovative, scalable, and equitable strategies for patient-centered care in addiction treatment. The funding mechanism allows for projects to span up to six years, divided into a two-year planning phase (R61) and a five-year implementation phase (R33), with an anticipated total funding of up to $15 million based on the quality of applications received. Interested applicants can find more details and submission guidelines at the provided link and should direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov. The application deadline is March 20, 2025.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis" (RFA-DA-25-078), aimed at supporting research that transforms addiction treatment and care to combat the ongoing overdose crisis. This initiative encourages phased applications (R61/R33), where the R61 phase focuses on exploratory activities without the need for existing pilot data, while the R33 phase seeks to implement larger studies based on successful R61 milestones, emphasizing stigma-free and patient-centered approaches. With up to $10 million allocated for FY2026 and a maximum award period of six years, applicants must include a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity, and applications are to be submitted through Grants.gov by the closing date of March 20, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity under the HEAL Initiative, aimed at enhancing the implementation and sustainability of substance use preventive services. This initiative seeks to address the critical gaps between effective prevention research and its practical application, particularly in combating the opioid crisis, by soliciting applications for projects that demonstrate preliminary data and focus on strengthening prevention infrastructure. With approximately $4.65 million available for funding, grants can support projects for up to five years, with annual budget requests advised to remain under $800,000. Interested applicants must submit their proposals by January 16, 2026, and can find additional information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity under the HEAL Initiative aimed at enhancing the implementation of preventive services for substance use disorders, specifically focusing on opioid misuse. This initiative invites applications for research that addresses gaps in the dissemination and implementation of prevention services, with a phased R61/R33 award mechanism allowing for up to six years of support, contingent on the successful completion of preliminary milestones. The overarching goal is to establish a sustainable prevention infrastructure that effectively reduces risks associated with substance use, emphasizing equity and community involvement in the research process. Interested applicants can find more information and apply by the deadline of January 16, 2026, with a projected funding amount of $4.65 million for the 2024 fiscal year. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-066.html.
    HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01), aimed at supporting early career researchers in developing expertise in implementation science related to substance use treatment and prevention. Applicants are required to conduct an independent clinical trial that applies implementation science to one of the four priority domains of the HHS Overdose Prevention Strategy, which includes prevention, treatment, harm reduction, and recovery support services. This initiative is crucial in addressing the ongoing overdose crisis by promoting the integration of evidence-based practices into routine care, fostering a diverse research community, and ensuring equitable access to effective treatment resources. The funding amount is approximately $1.1 million for FY2023, with awards anticipated for 3-5 years of research, and applications are due by November 12, 2025. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the JCOIN Phase II Community Engaged Research Resource Center (CERRC), aimed at addressing the overdose crisis among individuals involved in the criminal-legal system. This initiative seeks to engage various stakeholders in researching effective interventions for substance use disorders (SUD) and enhancing continuity of care between public health and public safety agencies, with a focus on community engagement and diversity, equity, and inclusion (DEI). The funding, capped at $750,000 per year, is available for projects that include engaging individuals with lived experience, creating public resources for community-engaged research, and conducting rapid turnaround research projects, with applications due by January 23, 2025. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-026.html.
    HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a grant opportunity titled the HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23), aimed at supporting early career researchers and clinicians in the field of addiction. Applicants are required to have clinical training and must propose an independent clinical trial that aligns with the HHS Overdose Prevention Strategy, focusing on areas such as opioid misuse prevention, treatment, harm reduction, and recovery support services. This initiative is crucial for addressing the ongoing substance use crisis by fostering a new generation of implementation researchers who can effectively translate research into clinical practice. Interested applicants can find more information and apply by November 12, 2025, with funding support of up to $100,000 per year for salary and additional research costs. For inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the opportunity's webpage at http://grants.nih.gov/grants/guide/pa-files/PAS-22-207.html.
    Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at the development of medications to prevent and treat opioid and stimulant use disorders and overdose. This initiative seeks innovative preclinical and clinical research projects that can lead to FDA-approved therapies, focusing on areas such as prevention of substance use initiation, treatment adherence, and reduction of overdose risks. With a maximum funding amount of $3 million per year over a project period of five years, applicants are encouraged to submit proposals that demonstrate their capability to manage the research effectively, adhering to detailed application instructions. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for September 1, 2025.
    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative, titled "Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)." This initiative aims to support early-stage translational research focused on developing and validating tests for non-opioid analgesics, including small molecules and biologics, to address the ongoing opioid crisis and improve pain management. The program anticipates a funding pool of $2.5 million, with plans to award approximately 4-5 grants in FY 2025, and applications are due by January 15, 2027. Interested applicants can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.